首页> 外文期刊>Journal of Hepatocellular Carcinoma >Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
【24h】

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes

机译:切除NAFLD相关的HCC:患者选择和报告的结果

获取原文
       

摘要

Global prevalence of non-alcoholic fatty liver disease (NAFLD) has been growing in the last decades, especially in western countries, due to increased prevalence of diabetes, obesity or other components of metabolic syndrome. NAFLD recently became an important cause of hepatocellular carcinoma (HCC), even in non-cirrhotic patients. Patients with HCC-NAFLD are usually older, with more morbidities (especially cardiovascular diseases and metabolic disorders) and have advanced disease at the diagnosis due to the absence of surveillance, which is considered not cost-effective in patients without advanced fibrosis/cirrhosis, given the large prevalence of NAFLD in the general population. For these reasons, patients with HCC-NAFLD unlikely underwent curative treatments, and have been reported to have lower overall survival (OS) compared to individuals with HCC related to other aetiologies. However, this difference is not confirmed by data of patient subgroups who received curative treatment. In our review, we selected studies published over the past 8 years that analyse characteristics and outcomes of HCC-NAFLD patients who underwent surgery with the aim of identifying features that could predict outcomes and potential selection criteria. All the studies confirm that patients with HCC-NAFLD are older, with many comorbidities and that HCC occurs frequently even in non-cirrhotic livers. There is no agreement about intraoperative and perioperative complications. Regarding outcomes, all papers agree that patients with HCC in NAFLD who undergo surgery have a better OS compared to other aetiologies. Summarizing, surgery is a good curative option for patients with HCC-NAFLD, perhaps even better than transplantation in terms of OS. In this group of patients, it seems to be essential to evaluate cardio-pulmonary and general operative risk, in addition to the normal risk assessment related to liver function to avoid an underestimation, especially for patients without severe underlying ?brosis.
机译:由于糖尿病,肥胖或代谢综合征的其他组分增加,尤其是西方国家的非酒精脂肪肝疾病(NAFLD)的全球患病率一直在增长,特别是西方国家。 NAFLD最近成为肝细胞癌(HCC)的重要原因,即使在非肝硬化患者中。 HCC-NAFLD患者通常年龄较大,具有更多的病理(特别是心血管疾病和代谢紊乱),并且由于缺乏监测而导致的诊断中具有晚期疾病,这在没有先进的纤维化/肝硬化的患者中被认为是不具有成本效益一般人群中NAFLD的大流行。由于这些原因,与HCC-NAFLD的患者不太可能进行疗法,并且据报道,与与其他疾病的HCC有关的个体相比,据报道,总体存活率降低了整体存活率(OS)。然而,这种差异不是通过接受治疗治疗的患者亚组数据来证实。在我们的评论中,我们在过去的8年里出版的研究分析了接受手术的HCC-NAFLD患者的特征和结果,目的是识别可能预测结果和潜在选择标准的特征。所有研究确认,HCC-NAFLD患者年龄较大,许多合并症,即使在非循环肝脏中也经常发生HCC。没有关于术中和围手术期并发症的一致意见。关于结果,所有论文都认为,与其他疾病相比,患有HCC的HCC患者患有更好的操作系统。总结,手术是HCC-NAFLD患者的一个很好的治愈性选择,甚至比OS方面的移植更好。在这组患者中,除了与肝功能相关的正常风险评估外,避免低估的患者,似乎是评估心肌肺癌和一般手术风险的必要条件是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号